AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MURA
  4. [Form 4] Mural Oncology plc Insider Trading Activity

[Form 4] Mural Oncology plc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock MURA logo
Mural Oncology PLC

NASDAQ:MURA

MURA Rankings

#8133 Ranked by Market Cap
N/A Ranked by Dividends

MURA Latest News

Aug 4, 2025
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
May 19, 2025
Mural Oncology Announces Number of Relevant Securities in Issue
Apr 30, 2025
FORM 8.1(a) & (b) - Mural Oncology plc
Apr 15, 2025
Mural Oncology Announces Plans to Explore Strategic Alternatives
Mar 25, 2025
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer

MURA Latest SEC Filings

Aug 4, 2025
[10-Q] Mural Oncology plc Quarterly Earnings Report
Aug 4, 2025
[8-K] Mural Oncology plc Reports Material Event
Jul 23, 2025
[Form 4] Mural Oncology plc Insider Trading Activity
Jul 22, 2025
[144] Mural Oncology plc SEC Filing
Jul 9, 2025
[144] Mural Oncology plc SEC Filing

MURA Stock Data

40.06M
15.01M
13.07%
57.4%
1.35%
Biotechnology
Pharmaceutical Preparations
Ireland
DUBLIN 2